Clinical confidence starts with high-quality materials with a legacy of performance and innovation

By: Danielle Petra, Global Business Director, Ulteeva Purity™, Polyethylene Solutions at dsm-firmenich

Today’s device manufacturers face a complex set of demands from regulatory requirements and minimizing yield loss, to maintaining innovation in an increasingly competitive landscape. Material selection plays a critical role in meeting these challenges. 

Ulteeva Purity™ fibers are manufactured in a dedicated medical production facility with meticulous quality controls. Known for consistent performance, limited yield loss during processing, and enabling medical device designers to push the boundaries of what’s possible, Ulteeva Purity™ represents reliability in medical-grade fiber. A recent example is the release of green Ulteeva Purity™ fibers, a vibrant color that meets a clinical need of improving visualization in arthroscopy. 

A legacy of trust with Ulteeva Purity™

At Biomedical, we understand confidence is earned over time. It is built through decades of expertise, rigorous testing, and an unwavering commitment to quality. Ulteeva Purity™, our portfolio of high-performance polyethylenes, is grounded in this legacy. 

Trusted by leading medical device manufacturers worldwide, these materials have been proven across countless real-world applications. This history is supported by a secure, high-quality supply chain, deep application expertise, and adherence to the most stringent manufacturing standards. Choosing a material platform with a strong clinical history is, at its core, choosing confidence. 

Versatility designed for modern medical devices and procedures 

As medical devices and procedures become more sophisticated, they require materials that can perform reliably across a wide range of applications. When we look at our portfolio of medical-grade biomaterials, Ulteeva Purity™ polyethylene fibers are a great example of a product engineered for this versatility. Our UHMWPE fibers offer the broadest selection of medical-grade sizes and colors available today. 

Whether a design calls for ultra-fine fibers for delicate procedures or high-contrast colors to help improve surgical visualization, these materials enable innovation without compromise. This flexibility allows device designers to tailor solutions to specific procedural and patient needs while maintaining clinical confidence. 

A supply chain built for peace of mind 

We know in high-stakes clinical environments, reliability extends beyond material performance, it depends on supply continuity. Such supply chain disruptions can have serious downstream consequences for manufacturers and patients alike. 

That’s why our supply strategy is built on three pillars: consistent quality, dependable availability, and regulatory compliance. By maintaining a secure and resilient supply chain, we help our customers reduce risk, meet regulatory expectations, and deliver critical devices with confidence. 

Collaboration from concept to commercialization 

Here at Biomedical, we believe the strongest outcomes are achieved through partnership. By collaborating closely with our customers from the earliest stages of development through commercialization, we can help translate ideas into clinically proven solutions. 

Our experts provide hands-on support across prototyping, testing, regulatory preparation, and scale-up. This collaborative approach ensures manufacturers won’t navigate complexity alone and that innovation progresses with confidence at every stage. 

Evolving for a healthier future 

As we continue to look at the future and work with leading medical device manufacturers, one thing remains clear: medical innovation never stands still, and neither do we. We continue to expand the Ulteeva Purity™ portfolio with new fiber sizes, colors, and advanced formats including membranes and powders to support next-generation device designs. 

Sustainability has been and continues to be a key focus for us at dsm-firmenich. Through the use of renewable energy in our production facilities and ISCC Plus certification, Ulteeva Purity™ fibers deliver up to a 70% reduction in carbon emissions compared to some alternatives. In addition, our polyethylene membranes offer a sustainable alternative to fluoropolymers such as PTFE, addressing both environmental and supply chain concerns. 

This commitment to continuous improvement will help us to ensure our materials remain at the forefront of medical innovation today and well into the future.